1. Home
  2. TENB vs KRYS Comparison

TENB vs KRYS Comparison

Compare TENB & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenable Holdings Inc.

TENB

Tenable Holdings Inc.

N/A

Current Price

$24.83

Market Cap

3.5B

Sector

Technology

ML Signal

N/A

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

N/A

Current Price

$237.22

Market Cap

6.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TENB
KRYS
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
6.3B
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
TENB
KRYS
Price
$24.83
$237.22
Analyst Decision
Buy
Strong Buy
Analyst Count
17
9
Target Price
$39.25
$214.22
AVG Volume (30 Days)
1.2M
287.5K
Earning Date
02-04-2026
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
275.72
EPS
N/A
6.66
Revenue
$974,603,000.00
$373,164,000.00
Revenue This Year
$12.22
$36.14
Revenue Next Year
$7.62
$41.80
P/E Ratio
N/A
$35.81
Revenue Growth
11.05
54.51
52 Week Low
$24.24
$122.80
52 Week High
$45.45
$248.60

Technical Indicators

Market Signals
Indicator
TENB
KRYS
Relative Strength Index (RSI) 31.60 70.65
Support Level $24.24 $213.83
Resistance Level $27.24 $248.60
Average True Range (ATR) 0.60 7.15
MACD -0.09 0.54
Stochastic Oscillator 19.80 71.78

Price Performance

Historical Comparison
TENB
KRYS

About TENB Tenable Holdings Inc.

Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: